GenVec Message Board - Msg: 4305991

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : GenVec

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

To: Beltropolis Boy who wrote ()	5/3/1998 5:57:00 PM
From: Beltropolis Boy	Read Replies (1) of 19

Varian and GenVec Reach Agreement to Jointly Develop New Therapy Products Tuesday, April 7 11:02 AM ET Collaboration On Combining Radiotherapy With Novel Gene Constructs Aimed At Enhanced Therapy Techniques, New Products for Fighting Cancer PALO ALTO, Calif. (BW HealthWire) - Varian Biosynergy, Inc., a subsidiary of Varian Associates, Palo Alto, California and GenVec, Inc., Rockville, Maryland today announced the signing of a development agreement to jointly exploit the potential of combining advances in targeted radiation with gene therapy in the treatment of cancer and other diseases. my.excite.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext